Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

House Members Take STAND On Tianeptine As ‘Unregulated Drug’ In Supplements

Jan 26 2024

• By Malcolm Spicer

• Source: Shutterstock

Related Content

Absent Mandatory Listing, US FDA Acknowledges Its Supplement Directory Isn’t Comprehensive

Mar 07 2023

Congress Boosts FDA Food Safety Budget Nearly $700M, Orders Reports On Formula Supply

Jan 02 2023

Tianeptine Rings Latest Unapproved Drug Alarm, Followed By Echo About Lack Of FDA Regulation

Nov 28 2023

Opioid Treatment Claims Linked To Depression Drug Found In Supplements

Nov 21 2018

US FDA Testing Finds Consumer Health Market Problems, But It Can’t Test Entire Marketplace

Sep 22 2021

Additional Topics

United States US States International Dietary Supplements Politics FDA Advertising, Marketing & Sales Commercial Companies Compliance Consumer Enforcement E-Commerce Ingredients Legislation Policy Recalls Regulation Regulatory Retail Safety

More from Regulation

More from Policy & Regulation

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window